Literature DB >> 15515411

Immunomodulatory function of the 5-HT3 receptor antagonist tropisetron.

E M Schneider1, X Ma, T Stratz, W Müller, I Lorenz, W D Seeling.   

Abstract

OBJECTIVE: To characterize the immune modulatory effects of 5-HT3 receptor antagonist treatment in patients with fibromyalgia, autoimmune disorders, and chronic pain.
METHODS: Multiplex-assisted cytokine measurements were performed before and during treatment. Whole blood stimulation with TNF-alpha was carried out to determine the proinflammatory response induced by exogenous TNF-alpha.
RESULTS: Five of nine patients clinically responded to treatment, and two had a moderate response. All patients had significantly elevated levels of T-H1 cytokines more prominent than TNF-alpha, IL-1beta, and IL-6. Treatment resulted in transient effects on peripheral monocyte counts in all but one patient, a plasma IL-1beta increase in two responder patients, and decreased T-H1 cytokines in two responder patients. Ex vivo TNF-alpha stimulation was transiently reconstituted in three responder patients to a significant level. Three patients showed a marginal reconstitutive response.
CONCLUSION: 5-HT3 receptor blockade transiently affects monocyte tissue infiltration, modulates T-H1 cytokines in clinical responders as well as MIP-1beta in moderate responders, and transiently affects the ex vivo response to exogenous TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15515411

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  3 in total

Review 1.  The relationship between the serotonergic system and COVID-19 disease: A review.

Authors:  Tahereh Eteraf-Oskouei; Moslem Najafi
Journal:  Heliyon       Date:  2022-05-26

Review 2.  Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses.

Authors:  Helen Irving; Ilona Turek; Christine Kettle; Nor Yaakob
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

3.  Repeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial.

Authors:  Nikolaos Christidis; Shahin Omrani; Lars Fredriksson; Mattias Gjelset; Sofia Louca; Britt Hedenberg-Magnusson; Malin Ernberg
Journal:  J Headache Pain       Date:  2015-12-03       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.